written on 14.03.2014

Gilead's hot-selling Sovaldi draws more patent attacks


Gilead Sciences' Sovaldi portends to be a megablockbuster by the end of this year–and possibly the biggest-selling drug of all time a few years down the road. So it's no surprise that others are after a piece of the drug–Idenix Pharmaceuticals included.